Oncimmune (LON:ONC) Shares Down 0.6%

Oncimmune Holdings plc (LON:ONCGet Rating) shares dropped 0.6% on Friday . The stock traded as low as GBX 84 ($1.01) and last traded at GBX 85 ($1.02). Approximately 23,648 shares traded hands during trading, a decline of 56% from the average daily volume of 54,092 shares. The stock had previously closed at GBX 85.50 ($1.03).

Oncimmune Stock Down 0.6 %

The company has a market capitalization of £59.05 million and a PE ratio of -8.33. The company’s 50 day moving average is GBX 89.21 and its two-hundred day moving average is GBX 117.40. The company has a quick ratio of 1.04, a current ratio of 1.08 and a debt-to-equity ratio of 677.62.

About Oncimmune

(Get Rating)

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.

Further Reading

Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.